Citation Information :
Jain P, Batta AK, Singh P. Comparative Study of Serum Levels of Gamma-glutamyl Transferase, Aspartate Aminotransferase (AST), Alanine Transaminase (ALT), AST:ALT, and Bilirubin in Patients with Chronic Hepatitis. Indian J Med Biochem 2022; 26 (3):73-76.
Introduction: Viral hepatitis and other liver-related diseases are mostly difficult to diagnose solely based on clinical regimes. Liver damage results in alterations in serum enzyme patterns which have been used to develop many enzyme-based assays.
Aim and objectives: The major clinical consequences of chronic liver disease can be evaluated by liver function tests like bilirubin, gamma-glutamyl transferase (GGT), aspartate aminotransferase (AST), and alanine transaminase (ALT). Alanine transaminase and AST changes indicate leakage from damaged hepatocytes. The present study was conducted to compare the serum levels of GGT, AST, ALT, AST:ALT ratio, and bilirubin in patients with chronic hepatitis.
Materials and methods: The study group comprised 100 clinically diagnosed patients with chronic hepatitis and 100 controls.
Results: Case–control comparison showed statistically higher values of GGT (p < 0.01), AST (p < 0.05), ALT (p < 0.05), AST:ALT (p < 0.01), and bilirubin (p < 0.05) in cases and serum levels of GGT, AST:ALT, and bilirubin were sensitive and specific when various parameters were compared with each other in various hepatitis and controls.
Conclusion: The present study indicates that the parameters GGT, AST, ALT, AST:ALT ratio, and bilirubin are associated with increased risk of hepatitis.
Clinical significance: The serum levels of GGT, AST, ALT, AST:ALT ratio, and bilirubin can be used for the biochemical profiling of different types of patients with hepatitis.
Chawla R. Practical clinical biochemistry: methods and interpretations. JP Medical Ltd; 2014.
Lala V, Goyal A, Minter DA. Liver function tests. In StatPearls [Internet] 2021 Aug 20. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK482489/.
Rosalki SB, Tarlow D, Rau D. Plasma gamma-glutamyl transpeptidase elevation in patients receiving enzyme inducing drugs. Lancet 1971;2(7720):376–377. DOI: 10.1016/s0140-6736(71)90093-6.
McCullough AJ. Update on nonalcoholic fatty liver disease. J Clin Gastroenterol 2002;34(3):255–262. DOI: 10.1097/00004836-200203000-00013.
Giannini E, Botta F, Fasoli A, et al. Increased levels of gammaGT suggest the presence of bile duct lesions in patients with chronic hepatitis C: absence of influence of HCV genotype, HCV-RNA serum levels and HGV infection on this histological damage. Dig Dis Sci 2001;46(3):524–529. DOI: 10.1023/a:1005534929304.
Cohen JA, Kaplan MM. The SGOT/SGPT ratio–An indicator of alcoholic liver disease. Dig Dis Sci 1979;24(11):835–838. DOI: 10.1007/BF01324898.
Woreta TA, Alqahtani SA. Evaluation of abnormal liver tests. Med Clin 2014;98(1):1–6. DOI: 10.1016/j.mcna.2013.09.005.
Franklin Herlong FH, Mitchell MC. Laboratory tests. In: Maddrey WC, Schiff ER, Sorrell MF (Eds). Schiff's Diseases of the Liver. Wiley-Blackwell; USA: 2012. pp. 17–43.
Mukherjee S, Gollan JL. Assessment of liver function. In: Lok AS, Dooley JS, Burroughs AK, et al. (Eds). Sherlock's Diseases of the Liver and Biliary System. Wiley-Blackwell; USA: 2011. pp. 20–35.
Patil VS, Desai PB, Kodliwadmath MV, et al. Utility of gamma glutamyltransferase and AST/ALT (De Ritis) ratio in alcoholic liver diseases. Int J Med Sci Technol 2011;4(1):1.
Batta A. Comparative study of transaminase ratio, AST, ALT and GGT in cases of chronic hepatitis. Int J Med Health Res 2019;5(1):31–35.
Mohamad MN, Pourshams A, Malekzadeh R, et al. Healthy ranges of serum alanine aminotransferase levels in Iranian blood donors. World J Gastroenterol 2003;9(10):2322–2324. DOI: 10.3748/wjg.v9.i10.2322.
Prati D, Taioli E, Zanella A, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002;137(1):1–10. DOI: 10.7326/0003-4819-137-1-200207020-00006.
Puoti C, Castellacci R, Montagnese F. Hepatitis C virus carriers with persistently normal aminotransferase levels: Healthy people or true patients? Dig Liver Dis 2000;32(7):634–643. DOI: 10.1016/s1590-8658(00)80850-6.
Shiffman ML, Diago M, Tran A, et al. Chronic hepatitis C in patients with persistently normal alanine transaminase levels. Clin Gastroenterol Hepatol 2006;4:645–652. DOI: 10.1016/j.cgh.2006.02.002.
Nyblom H, Berggren U, Balldin J, et al. High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking. Alcohol Alcohol 2004;39(4):336–339. DOI: 10.1093/alcalc/agh074.